CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><link rel="icon" type="image/png" href="https://assets.brighttalk.com/images/favicon.ico"/><link rel="apple-touch-icon" href="https://assets.brighttalk.com/images/favicon.ico"/><link rel="canonical" href="https://www.brighttalk.com/webcast/8395/618737"/><title>Future-proof your drug development investment with robust IP search strategies</title><meta name="description" content="A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time..."/><meta property="og:type" content="website"/><meta name="og:title" property="og:title" content="Future-proof your drug development investment with robust IP search strategies"/><meta name="og:description" property="og:description" content="A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money. How do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable. In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including: • Essential novelty searches for pharmaceutical substances; • Tips for advanced IP search strategies and how they help to protect your research investment; and • The importance and hallmarks of trustworthy IP tools and partners."/><meta property="og:site_name" content="BrightTALK"/><meta property="og:url" content="https://www.brighttalk.com/webcast/8395/618737"/><meta name="brighttalk-channel-id" content="8395"/><meta name="brighttalk-page-architecture" content="react"/><meta name="brighttalk-page-name" content="webcast"/><meta name="brighttalk-content-status" content="recorded"/><meta name="brighttalk-community" content="Intellectual Property"/><meta name="brighttalk-community-parent" content="Legal"/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Future-proof your drug development investment with robust IP search strategies"/><meta name="twitter:description" content="A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money. How do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable. In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including: • Essential novelty searches for pharmaceutical substances; • Tips for advanced IP search strategies and how they help to protect your research investment; and • The importance and hallmarks of trustworthy IP tools and partners."/><meta name="twitter:site" content="BrightTALK"/><meta name="twitter:creator" content=""/><meta property="og:image" content="https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360"/><meta name="twitter:image" content="https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360"/><meta name="viewport" content="initial-scale=1.0, width=device-width"/><meta name="robots" content="noindex,follow"/><script type="application/ld+json">{"@context":"https://schema.org","@type":"Event","name":"Future-proof your drug development investment with robust IP search strategies","description":"A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money.\n\nHow do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable.\n\nIn this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including:\n• Essential novelty searches for pharmaceutical substances;\n• Tips for advanced IP search strategies and how they help to protect your research investment; and\n• The importance and hallmarks of trustworthy IP tools and partners.","about":"A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money.\n\nHow do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable.\n\nIn this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including:\n• Essential novelty searches for pharmaceutical substances;\n• Tips for advanced IP search strategies and how they help to protect your research investment; and\n• The importance and hallmarks of trustworthy IP tools and partners.","startDate":"2024-07-24T16:00:00Z","endDate":"2024-07-24T16:00:54.000Z","url":"https://www.brighttalk.com/webcast/8395/618737","duration":"PT0H0M54S","location":{"@type":"VirtualLocation","name":"BrightTALK","url":"https://www.brighttalk.com/webcast/8395/618737","description":"A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money.\n\nHow do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable.\n\nIn this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including:\n• Essential novelty searches for pharmaceutical substances;\n• Tips for advanced IP search strategies and how they help to protect your research investment; and\n• The importance and hallmarks of trustworthy IP tools and partners.","image":"https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360"},"image":"https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360","performer":"MIP and CAS","organizer":{"@type":"Organization","name":"Legal Benchmarking Group","description":"Legal Benchmarking Group delivers marketing and business development solutions for law firms around the world. \n\nOur products and services include research, surveys and rankings, covering the leading firms and practitioners by practice areas, industries, and jurisdiction. \n\nOur key legal directory brands are IFLR1000, IP STARS, World Tax, Benchmark Litigation, LMG Life Sciences and Asialaw.\n\nWe also provide co-publishing and thought leadership content services to legal and advisory firms through our market-leading premium content brands: IFLR, Managing IP, International Tax Review.","url":"https://www.brighttalk.com/channel/8395"},"eventAttendanceMode":"OnlineEventAttendanceMode","eventStatus":"EventScheduled","aggregateRating":{"@type":"AggregateRating","bestRating":"5","worstRating":"1","ratingValue":5,"ratingCount":1}}</script><script async="" src="https://unpkg.com/date-time-format-timezone@latest/build/browserified/date-time-format-timezone-complete-min.js"></script><style type="text/css"> #cmp-banner { position: fixed; bottom: 0; left: 0; z-index: 1200; } @media (min-width: 960px) { #cmp-banner { bottom: 20px; left: 20px; } } #cmp-banner, #cmp-banner > div, #cmp-banner iframe { width: 300px; height: 275px; } #cmp-banner:empty { display: none; } </style><script type="text/javascript"> "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r<t;r++)n[r]=arguments[r];if(!n.length)return o;"setGdprApplies"===n[0]?n.length>3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); (function () { var e = false; var c = window; var t = document; function r() { if (!c.frames["__uspapiLocator"]) { if (t.body) { var a = t.body; var e = t.createElement("iframe"); e.style.cssText = "display:none"; e.name = "__uspapiLocator"; a.appendChild(e) } else { setTimeout(r, 5) } } } r(); function p() { var a = arguments; __uspapi.a = __uspapi.a || []; if (!a.length) { return __uspapi.a } else if (a[0] === "ping") { a[2]({ gdprAppliesGlobally: e, cmpLoaded: false }, true) } else { __uspapi.a.push([].slice.apply(a)) } } function l(t) { var r = typeof t.data === "string"; try { var a = r ? JSON.parse(t.data) : t.data; if (a.__cmpCall) { var n = a.__cmpCall; c.__uspapi(n.command, n.parameter, function (a, e) { var c = { __cmpReturn: { returnValue: a, success: e, callId: n.callId } }; t.source.postMessage(r ? JSON.stringify(c) : c, "*") }) } } catch (a) { } } if (typeof __uspapi !== "function") { c.__uspapi = p; __uspapi.msgHandler = l; c.addEventListener("message", l, false) } })(); window.__gpp_addFrame=function(e){if(!window.frames[e])if(document.body){var t=document.createElement("iframe");t.style.cssText="display:none",t.name=e,document.body.appendChild(t)}else window.setTimeout(window.__gpp_addFrame,10,e)},window.__gpp_stub=function(){var e=arguments;if(__gpp.queue=__gpp.queue||[],__gpp.events=__gpp.events||[],!e.length||1==e.length&&"queue"==e[0])return __gpp.queue;if(1==e.length&&"events"==e[0])return __gpp.events;var t=e[0],p=e.length>1?e[1]:null,s=e.length>2?e[2]:null;if("ping"===t)p({gppVersion:"1.1",cmpStatus:"stub",cmpDisplayStatus:"hidden",signalStatus:"not ready",supportedAPIs:["2:tcfeuv2","5:tcfcav1","6:uspv1","7:usnatv1","8:uscav1","9:usvav1","10:uscov1","11:usutv1","12:usctv1"],cmpId:0,sectionList:[],applicableSections:[],gppString:"",parsedSections:{}},!0);else if("addEventListener"===t){"lastId"in __gpp||(__gpp.lastId=0),__gpp.lastId++;var n=__gpp.lastId;__gpp.events.push({id:n,callback:p,parameter:s}),p({eventName:"listenerRegistered",listenerId:n,data:!0,pingData:{gppVersion:"1.1",cmpStatus:"stub",cmpDisplayStatus:"hidden",signalStatus:"not ready",supportedAPIs:["2:tcfeuv2","5:tcfcav1","6:uspv1","7:usnatv1","8:uscav1","9:usvav1","10:uscov1","11:usutv1","12:usctv1"],cmpId:0,sectionList:[],applicableSections:[],gppString:"",parsedSections:{}}},!0)}else if("removeEventListener"===t){for(var a=!1,i=0;i<__gpp.events.length;i++)if(__gpp.events[i].id==s){__gpp.events.splice(i,1),a=!0;break}p({eventName:"listenerRemoved",listenerId:s,data:a,pingData:{gppVersion:"1.1",cmpStatus:"stub",cmpDisplayStatus:"hidden",signalStatus:"not ready",supportedAPIs:["2:tcfeuv2","5:tcfcav1","6:uspv1","7:usnatv1","8:uscav1","9:usvav1","10:uscov1","11:usutv1","12:usctv1"],cmpId:0,sectionList:[],applicableSections:[],gppString:"",parsedSections:{}}},!0)}else"hasSection"===t?p(!1,!0):"getSection"===t||"getField"===t?p(null,!0):__gpp.queue.push([].slice.apply(e))},window.__gpp_msghandler=function(e){var t="string"==typeof e.data;try{var p=t?JSON.parse(e.data):e.data}catch(e){p=null}if("object"==typeof p&&null!==p&&"__gppCall"in p){var s=p.__gppCall;window.__gpp(s.command,(function(p,n){var a={__gppReturn:{returnValue:p,success:n,callId:s.callId}};e.source.postMessage(t?JSON.stringify(a):a,"*")}),"parameter"in s?s.parameter:null,"version"in s?s.version:"1.1")}},"__gpp"in window&&"function"==typeof window.__gpp||(window.__gpp=window.__gpp_stub,window.addEventListener("message",window.__gpp_msghandler,!1),window.__gpp_addFrame("__gppLocator")); window._sp_queue = []; window._sp_ = { config: { accountId: 370, baseEndpoint: 'https://cdn.privacy-mgmt.com', usnat: { includeUspApi: true }, gdpr: { }, events: { onMessageChoiceSelect: function (message_type, choice_id, choice_type_id) { // Code to make 'OK' and 'X' buttons work in the CPPA banner if(message_type === 'ccpa'){ console.log(choice_type_id); if(choice_type_id===11||choice_type_id===15){ document.getElementById("cmp-banner").style.display = "none"; } } }, onMessageReady: function() { console.log('[event] onMessageReady', arguments); }, onMessageChoiceError: function() { console.log('[event] onMessageChoiceError', arguments); }, onPrivacyManagerAction: function() { console.log('[event] onPrivacyManagerAction', arguments); }, onPMCancel: function() { console.log('[event] onPMCancel', arguments); }, onMessageReceiveData: function() { console.log('[event] onMessageReceiveData', arguments); }, onSPPMObjectReady: function() { console.log('[event] onSPPMObjectReady', arguments); }, onConsentReady: function (message_type, choice_type_id, choice_id, consentUUID, euconsent) { console.log('[event] onConsentReady', arguments); // Code to make 'OK' and 'X' buttons work in the CPPA banner if(message_type === 'usnat'){ if(document.getElementsByClassName('close-button')||document.getElementsByClassName('sp_choice_type_Accept')){ document.getElementById("cmp-banner").style.display = "none"; } } }, onError: function() { console.log('[event] onError', arguments); }, } } } </script><script src="https://cdn.privacy-mgmt.com/unified/wrapperMessagingWithoutDetection.js" async=""></script><meta name="next-head-count" content="31"/><script type="text/javascript"> window.dataLayer = window.dataLayer || []; function gtag() { dataLayer.push(arguments); } //default behavior gtag('consent', 'default', { 'ad_storage': 'granted', 'analytics_storage': 'granted', 'wait_for_update': 500 }); //behavior specific for end-users in the EEA gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied', 'region': ['BE', 'BG', 'CZ', 'DK', 'CY', 'LV', 'LT', 'LU', 'ES', 'FR', 'HR', 'IT', 'PL', 'PT', 'RO', 'SI', 'HU', 'MT', 'NL', 'AT', 'IS', 'LI', 'NO', 'SK', 'FI', 'SE', 'DE', 'EE', 'IE', 'EL'], 'wait_for_update': 500 }); </script><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push( {'gtm.start': new Date().getTime(),event:'gtm.js'} );var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NCXH7DF');</script><meta name="brighttalk-build"/><link rel="preload" href="https://assets.brighttalk.com/fonts/Roboto-Light.woff" as="font" type="font/woff" crossorigin="true"/><link rel="preload" href="https://assets.brighttalk.com/fonts/Roboto-Regular.woff" as="font" type="font/woff" crossorigin="true"/><link rel="preload" href="https://assets.brighttalk.com/fonts/Roboto-Bold.woff" as="font" type="font/woff" crossorigin="true"/><link rel="preload" href="https://assets.brighttalk.com/fonts/Roboto-Medium.woff" as="font" type="font/woff" crossorigin="true"/><script type="module" src="https://www.brighttalk.com/globalauth-helpercomponent/globalauth-helpercomponent.esm.js"></script><link rel="preload" href="/webcast/_next/static/css/f27ee2d0379f6a23.css" as="style"/><link rel="stylesheet" href="/webcast/_next/static/css/f27ee2d0379f6a23.css" data-n-g=""/><link rel="preload" href="/webcast/_next/static/css/96269a11e4525120.css" as="style"/><link rel="stylesheet" href="/webcast/_next/static/css/96269a11e4525120.css" data-n-p=""/><link rel="preload" href="/webcast/_next/static/css/ce5fea244d2c7257.css" as="style"/><link rel="stylesheet" href="/webcast/_next/static/css/ce5fea244d2c7257.css"/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/webcast/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script defer="" src="/webcast/_next/static/chunks/479.00bec7571fc3660a.js"></script><script src="/webcast/_next/static/chunks/webpack-b85caf12564da1cd.js" defer=""></script><script src="/webcast/_next/static/chunks/framework-aeb85a5e071ca0cb.js" defer=""></script><script src="/webcast/_next/static/chunks/main-5dfda2bd9643ffef.js" defer=""></script><script src="/webcast/_next/static/chunks/pages/_app-7ea91bd9cae06cc6.js" defer=""></script><script src="/webcast/_next/static/chunks/28455a0b-2cbae5c8e87fa36c.js" defer=""></script><script src="/webcast/_next/static/chunks/161-21e61a853b21e681.js" defer=""></script><script src="/webcast/_next/static/chunks/400-4e47201e7227ada6.js" defer=""></script><script src="/webcast/_next/static/chunks/9-a45af57e2b443b6a.js" defer=""></script><script src="/webcast/_next/static/chunks/pages/%5BchannelId%5D/%5BwebcastId%5D-5a1a962ff7432ecf.js" defer=""></script><script src="/webcast/_next/static/1079/_buildManifest.js" defer=""></script><script src="/webcast/_next/static/1079/_ssgManifest.js" defer=""></script><style id="__jsx-1440808217">.previewImg.jsx-1440808217{background:url(https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360)center center no-repeat;-webkit-filter:blur(4rem)grayscale(30%);filter:blur(4rem)grayscale(30%);opacity:.17;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;width:100%;height:100%;-webkit-transform:scale(1.1);-moz-transform:scale(1.1);-ms-transform:scale(1.1);-o-transform:scale(1.1);transform:scale(1.1)}</style><style id="__jsx-81224b3dde91c69d">.global-footer.jsx-81224b3dde91c69d{background-color:rgb(92,92,92);min-height:394px}</style> <script>!function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="JVT9R-JD38W-BPCAY-8MYGM-PYXBG",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!window.BOOMR||!window.BOOMR.version&&!window.BOOMR.snippetExecuted){window.BOOMR=window.BOOMR||{},window.BOOMR.snippetStart=(new Date).getTime(),window.BOOMR.snippetExecuted=!0,window.BOOMR.snippetVersion=12,window.BOOMR.url=n+"JVT9R-JD38W-BPCAY-8MYGM-PYXBG";var i=document.currentScript||document.getElementsByTagName("script")[0],o=!1,r=document.createElement("link");if(r.relList&&"function"==typeof r.relList.supports&&r.relList.supports("preload")&&"as"in r)window.BOOMR.snippetMethod="p",r.href=window.BOOMR.url,r.rel="preload",r.as="script",r.addEventListener("load",e),r.addEventListener("error",function(){t(!0)}),setTimeout(function(){if(!o)t(!0)},3e3),BOOMR_lstart=(new Date).getTime(),i.parentNode.appendChild(r);else t(!1);if(window.addEventListener)window.addEventListener("load",a,!1);else if(window.attachEvent)window.attachEvent("onload",a)}}(),"".length>0)if(e&&"performance"in e&&e.performance&&"function"==typeof e.performance.setResourceTimingBufferSize)e.performance.setResourceTimingBufferSize();!function(){if(BOOMR=e.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var n=""=="true"?1:0,t="",a="bdpnbeqxzkcqqz2g3uua-f-f2df31a8d-clientnsv4-s.akamaihd.net",i="false"=="true"?2:1,o={"ak.v":"39","ak.cp":"87120","ak.ai":parseInt("390532",10),"ak.ol":"0","ak.cr":4,"ak.ipv":4,"ak.proto":"http/1.1","ak.rid":"c51fc95","ak.r":47863,"ak.a2":n,"ak.m":"b","ak.n":"essl","ak.bpcip":"8.222.208.0","ak.cport":55730,"ak.gh":"23.54.158.70","ak.quicv":"","ak.tlsv":"tls1.2","ak.0rtt":"","ak.0rtt.ed":"","ak.csrc":"-","ak.acc":"reno","ak.t":"1732697384","ak.ak":"hOBiQwZUYzCg5VSAfCLimQ==AdH7jgHrZz/QSbAE9yJRuFBWtdsRorfwlEsLFcqqvsgOGOmvC9M3D5oFFxsww7CQ8egIbPQZtUQMx0BlBlX+Lhc2CmGuUr6G5rlfcvuGQvc/agXyROE1R+WP2as5SvmSTdHDmIsMSP1pJUt/FRqcd45gsHZjj56JdQOl9A0jA/E2e0CTl9Rax3pQ+l5HXpdvQYvbenVUvwScHHvnSptwF61/JlztF7Ef4oPegQkFg1gZSL6dSMbbV8dYWwLouDdIGY3HbH5COhYnw7kUO9Kg/eLaBoHSqDCNep/x59po9WADfBRZotPieHKMWUa0aR5rM/iICn56+sgjLi3gUmXIRFhJmxMDe9nCqM58DGbkwn2a0MrRz6GtcF0hCFOH39TUuFEkJQbAKBcICghOjsA3lquhfjczAVftXxmSYrQ62to=","ak.pv":"286","ak.dpoabenc":"","ak.tf":i};if(""!==t)o["ak.ruds"]=t;var r={i:!1,av:function(n){var t="http.initiator";if(n&&(!n[t]||"spa_hard"===n[t]))o["ak.feo"]=void 0!==e.aFeoApplied?1:0,BOOMR.addVar(o)},rv:function(){var e=["ak.bpcip","ak.cport","ak.cr","ak.csrc","ak.gh","ak.ipv","ak.m","ak.n","ak.ol","ak.proto","ak.quicv","ak.tlsv","ak.0rtt","ak.0rtt.ed","ak.r","ak.acc","ak.t","ak.tf"];BOOMR.removeVar(e)}};BOOMR.plugins.AK={akVars:o,akDNSPreFetchDomain:a,init:function(){if(!r.i){var e=BOOMR.subscribe;e("before_beacon",r.av,null,null),e("onbeacon",r.rv,null,null),r.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script></head><body><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NCXH7DF" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><div id="__next"> <div class="PageContent_app__Tw3yY"><div id="cmp-banner"></div><div class="ClientHeader_ClientHeader__Yhcmr ClientHeader_ClientHeader-basics__Tkt9O" data-preview-img="https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360" aria-hidden="true" data-bdd="client-header"><div class="jsx-1440808217 previewImg"></div><div class="ClientHeader_ClientHeader--Gradient___ql1Q ClientHeader_ClientHeader-basics__Tkt9O"></div></div><span><div class="global-header"><link rel="modulepreload" href="https://www.brighttalk.com/webcomponent/dist/brighttalk-web-components/brighttalk-web-components.esm.js"/><style> .global-header { background-color: white; min-height: 106px; margin-bottom: 30px; } </style></div></span><div class="Container_Container__cJtME PageContent_Player-Content__cuHLP"><main class="PageContent_Player-Content-Main__dT2hM" id="bt-player-content-main"><section class="Section_Section30__FyFjI"><h1 data-bdd="player-webcast-title">Future-proof your drug development investment with robust IP search strategies</h1><section class="Section_Section10__MY7SZ WebcastHeader_WebcastHeader-Subheader-Container__eoyOs" data-bdd="player-webcast-content"><div class="WebcastHeader_WebcastHeader-Subheader__2hOd6"><time class="WebcastHeader_WebcastHeader-Duration__Ojp_n" data-bdd="player-webcast-duration" dateTime="54m"><span>Duration: </span><span>54 mins</span></time></div><div class="WebcastHeader_WebcastHeader-Extra__mYsCW"></div></section><section class="Section_Section40__iljNL DefaultWebcastContent_DefaultWebcastContent--pad-right__m0r9W"><div class="PlayerPlaceholder_outer__erL98" data-bdd="player-placeholder"><div class="PlayerPlaceholder_PlayerPlaceholder__E0yEP" id="default-placeholder"><div style="--aspect-ratio:(16/9)" data-bdd="thumbnail-container" class="Thumbnail_thumbnail__nQlEr Thumbnail_thumbnail--small__tLn5m PlayerPlaceholder_PlayerPlaceholder-ThumbnailIE__p2acC PlayerPlaceholder_PlayerPlaceholder--max-height__ylfXH PlayerPlaceholder_PlayerNoCrusor__AAgzp"><img src="https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640&height=360" alt="" class="Thumbnail_thumbnail-img__Odh48" data-bdd="player-placeholder-thumbnail" width="647" height="364"/></div></div></div></section><section data-bdd="player-details"><article class="DefaultWebcastContent_DefaultWebcastContent-article__NVTL1"><h2 class="DefaultWebcastContent_DefaultWebcastContent-Header3__AZoDj"><div data-bdd="player-channel-logo" class="Thumbnail_thumbnail__nQlEr Thumbnail_thumbnail--borderless__hCROE Thumbnail_thumbnail--bg-transparent__YK03i DefaultWebcastContent_DefaultWebcastContent-ChannelLogo__PbB1y"><img src="https://cdn.brighttalk.com/ams/california/images/channel/8395/image_977637.png?width=300&height=300" alt="Logo" class="Thumbnail_thumbnail-img__Odh48" width="40" height="40"/></div><span>Presented by</span></h2><p class="DefaultWebcastContent_DefaultWebcastContent-P__e8prc" data-bdd="player-presenter">MIP and CAS</p></article><article><h2 class="DefaultWebcastContent_DefaultWebcastContent-Header3__AZoDj">About this talk</h2><div class="DefaultWebcastContent_DefaultWebcastContent-P__e8prc" data-bdd="player-body"><div class="Markdown_Markdown__kIRZG">A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money. How do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable. In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including: • Essential novelty searches for pharmaceutical substances; • Tips for advanced IP search strategies and how they help to protect your research investment; and • The importance and hallmarks of trustworthy IP tools and partners.</div></div></article></section></section><section class="Section_Section30__FyFjI RelatedTopics_RelatedTopics__J973v" data-bdd="related-topic"><div class="RelatedTopics_RelatedTopics-Label__Qc2fT" data-bdd="related-topic-header">Related topics:</div><div class="RelatedTopics_RelatedTopics-Items__VQabW" data-bdd="related-topic-items"><a href="https://www.brighttalk.com/topic/mip" class="RelatedTopics_RelatedTopics-Link__p7ZnJ" data-bdd="related-topic-0-link"><div class="RelatedTopics_RelatedTopics-Item__T42J0" data-bdd="related-topic-0-text">MIP</div></a><a href="https://www.brighttalk.com/topic/drug-development" class="RelatedTopics_RelatedTopics-Link__p7ZnJ" data-bdd="related-topic-1-link"><div class="RelatedTopics_RelatedTopics-Item__T42J0" data-bdd="related-topic-1-text">Drug Development</div></a><a href="https://www.brighttalk.com/topic/intellectual-property" class="RelatedTopics_RelatedTopics-Link__p7ZnJ" data-bdd="related-topic-2-link"><div class="RelatedTopics_RelatedTopics-Item__T42J0" data-bdd="related-topic-2-text">Intellectual Property</div></a><a href="https://www.brighttalk.com/topic/patents" class="RelatedTopics_RelatedTopics-Link__p7ZnJ" data-bdd="related-topic-3-link"><div class="RelatedTopics_RelatedTopics-Item__T42J0" data-bdd="related-topic-3-text">Patents</div></a></div></section><section class="Section_Section20__bSvI1" data-bdd="channel-info"><div class="SectionHeading_SectionHeading__NkeuR"><h3 data-bdd="channel-info-header" class="">More from this channel</h3></div><div class="ChannelInfo_ChannelInfo__oTF6i"><div class="ChannelInfo_ChannelInfo-Header__Fx7LJ"><a href="https://www.brighttalk.com/channel/8395/" title="Visit Legal Benchmarking Group's channel" class="ChannelInfo_ChannelInfo-Link__PqzoP globalStyle_hnm___IQTm" data-bdd="channel-info-channel-link"><span class="ChannelInfo_ChannelInfo-Logo__iCERc" data-bdd="channel-info-logo"><div data-bdd="thumbnail-container" class="Thumbnail_thumbnail__nQlEr Thumbnail_thumbnail--borderless__hCROE Thumbnail_thumbnail--bg-transparent__YK03i"><img src="https://cdn.brighttalk.com/ams/california/images/channel/8395/image_977637.png?width=300&height=300" alt="Legal Benchmarking Group logo" class="Thumbnail_thumbnail-img__Odh48" width="40" height="40"/></div></span><span class="ChannelInfo_ChannelInfo-Name__36UR1" data-bdd="channel-info-name">Legal Benchmarking Group</span></a></div><div class="ChannelInfo_ChannelInfo-Body__Vnmoe"><div class="ChannelInfo_ChannelInfo-Summary__eNUvy"><div class="ChannelInfo_ChannelInfo-SummaryItem--margin__5IC63"><span class="ChannelInfo_ChannelInfo-SummaryIcon__vypMF"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="calendar" class="svg-inline--fa fa-calendar getColorClass_text-secondary__5o8tz ChannelInfo_ChannelInfo--grey__D2sZ4" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" data-bdd="item-calendarSolid"><path fill="currentColor" d="M96 32V64H48C21.5 64 0 85.5 0 112v48H448V112c0-26.5-21.5-48-48-48H352V32c0-17.7-14.3-32-32-32s-32 14.3-32 32V64H160V32c0-17.7-14.3-32-32-32S96 14.3 96 32zM448 192H0V464c0 26.5 21.5 48 48 48H400c26.5 0 48-21.5 48-48V192z"></path></svg></span><span class="ChannelInfo_ChannelInfo-SummaryText__pbg3I" data-bdd="channel-info-upcoming">Upcoming talks (<b>2</b>)</span></div><div class="ChannelInfo_ChannelInfo-SummaryItem--margin__5IC63"><span class="ChannelInfo_ChannelInfo-SummaryIcon__vypMF"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="play" class="svg-inline--fa fa-play getColorClass_text-secondary__5o8tz ChannelInfo_ChannelInfo--grey__D2sZ4" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512" data-bdd="item-play"><path fill="currentColor" d="M73 39c-14.8-9.1-33.4-9.4-48.5-.9S0 62.6 0 80V432c0 17.4 9.4 33.4 24.5 41.9s33.7 8.1 48.5-.9L361 297c14.3-8.7 23-24.2 23-41s-8.7-32.2-23-41L73 39z"></path></svg></span><span class="ChannelInfo_ChannelInfo-SummaryText__pbg3I" data-bdd="channel-info-ondemand">On-demand talks (<b>110</b>)</span></div><div><span class="ChannelInfo_ChannelInfo-SummaryIcon__vypMF"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="users" class="svg-inline--fa fa-users getColorClass_text-secondary__5o8tz ChannelInfo_ChannelInfo--grey__D2sZ4" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 640 512" data-bdd="item-users"><path fill="currentColor" d="M144 0a80 80 0 1 1 0 160A80 80 0 1 1 144 0zM512 0a80 80 0 1 1 0 160A80 80 0 1 1 512 0zM0 298.7C0 239.8 47.8 192 106.7 192h42.7c15.9 0 31 3.5 44.6 9.7c-1.3 7.2-1.9 14.7-1.9 22.3c0 38.2 16.8 72.5 43.3 96c-.2 0-.4 0-.7 0H21.3C9.6 320 0 310.4 0 298.7zM405.3 320c-.2 0-.4 0-.7 0c26.6-23.5 43.3-57.8 43.3-96c0-7.6-.7-15-1.9-22.3c13.6-6.3 28.7-9.7 44.6-9.7h42.7C592.2 192 640 239.8 640 298.7c0 11.8-9.6 21.3-21.3 21.3H405.3zM224 224a96 96 0 1 1 192 0 96 96 0 1 1 -192 0zM128 485.3C128 411.7 187.7 352 261.3 352H378.7C452.3 352 512 411.7 512 485.3c0 14.7-11.9 26.7-26.7 26.7H154.7c-14.7 0-26.7-11.9-26.7-26.7z"></path></svg></span><span class="ChannelInfo_ChannelInfo-SummaryText__pbg3I" data-bdd="channel-info-subscribers">Subscribers (<b>14769</b>)</span></div></div><div class="ChannelInfo_ChannelInfo-Description__x_HRU" data-bdd="channel-info-body"><span data-bdd="channel-info-description" width="0"><span></span><span>Legal Benchmarking Group delivers marketing and business development solutions for law firms around the world. Our products and services include research, surveys and rankings, covering the leading firms and practitioners by practice areas, industries, and jurisdiction. Our key legal directory brands are IFLR1000, IP STARS, World Tax, Benchmark Litigation, LMG Life Sciences and Asialaw. We also provide co-publishing and thought leadership content services to legal and advisory firms through our market-leading premium content brands: IFLR, Managing IP, International Tax Review.</span><span style="position:fixed;visibility:hidden;top:0;left:0">…</span></span></div></div></div></section></main><aside class="PageContent_Player-Content-Aside__ejqAg"><div class="SidePanel_form-wrapper__XAlVE"><div class="SidePanel_globalauth-wrapper__fRQUj"><div class="SidePanel_spinner-wrapper__vIlwe"><div class="GlobalAuthSkeleton_wrapper__bWg5s"><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_heading__oXy64"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_input__q43DK"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_button__Ji96E"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_text___CPXT"></div><div class="GlobalAuthSkeleton_privacy-text__U75_Y"><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_text___CPXT"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_text___CPXT"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_text___CPXT"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_text___CPXT"></div><div class="GlobalAuthSkeleton_skeleton-loader-item__QXrVE GlobalAuthSkeleton_text-1__a9eLg"></div></div></div></div></div></div></aside></div><div class="jsx-81224b3dde91c69d global-footer"><portal-footer env="prod" className="jsx-81224b3dde91c69d"></portal-footer></div></div> </div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"channelId":"8395","webcastId":"618737","channel":{"id":8395,"statistics":{"upcomingCommunications":"2","liveCommunications":"0","recordedCommunications":"110","subscribers":"14769","viewedSeconds":"34055633"},"channelName":"Legal Benchmarking Group","channelUrl":"https://www.brighttalk.com/channel/8395","channelDescription":"Legal Benchmarking Group delivers marketing and business development solutions for law firms around the world. \n\nOur products and services include research, surveys and rankings, covering the leading firms and practitioners by practice areas, industries, and jurisdiction. \n\nOur key legal directory brands are IFLR1000, IP STARS, World Tax, Benchmark Litigation, LMG Life Sciences and Asialaw.\n\nWe also provide co-publishing and thought leadership content services to legal and advisory firms through our market-leading premium content brands: IFLR, Managing IP, International Tax Review.","visibility":"excluded","channelImg":"https://cdn.brighttalk.com/ams/california/images/channel/8395/image_977637.png?width=300\u0026height=300","locale":"en-US","showAttendees":false,"showShare":true,"showSocial":true},"webcast":{"id":618737,"channel":{"id":8395},"title":"Future-proof your drug development investment with robust IP search strategies","description":"A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money.\n\nHow do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable.\n\nIn this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including:\n• Essential novelty searches for pharmaceutical substances;\n• Tips for advanced IP search strategies and how they help to protect your research investment; and\n• The importance and hallmarks of trustworthy IP tools and partners.","presenter":"MIP and CAS","duration":54,"keywords":"MIP, Drug Development, Intellectual Property, Patents","start":"2024-07-24T16:00:00Z","entryTime":"2024-07-24T15:55:00Z","end":"","status":"recorded","timeZone":"Europe/London","url":"https://www.brighttalk.com/webcast/8395/618737","isGigCancelled":false,"previewImg":"https://cdn.brighttalk.com/ams/california/images/communication/618737/image_988999.png?width=640\u0026height=360","topics":[{"title":"MIP","url":"https://www.brighttalk.com/topic/mip"},{"title":"Drug Development","url":"https://www.brighttalk.com/topic/drug-development"},{"title":"Intellectual Property","url":"https://www.brighttalk.com/topic/intellectual-property"},{"title":"Patents","url":"https://www.brighttalk.com/topic/patents"}],"pageState":"ondemand","visibility":"public","syndication":null,"rating":5,"ratingCount":1},"summit":{"eventCount":0,"img":"","link":"","live":[],"onDemand":[],"showTracks":false,"summitDate":"","title":"","tracks":[],"upcoming":[],"target":"","type":""},"webcastCommunities":{"communities":[{"id":2,"title":"Legal","description":"The legal community on BrightTALK combines the fields of employment law, e-discovery, intellectual property and environmental law to create a thriving ecosystem of legal resources. Attend live and on-demand webinars dealing with employment contract law, e-discovery solutions, intellectual property software and sustainable development from leading lawyers and legal professionals to gain knowledge in a wide range of fields. Join the community and be part of the conversation by attending live legal webinars and connecting with industry thought leaders.","alias":"legal","entryCount":3066,"childCount":1,"enabled":true,"primary":false,"children":[{"id":32,"title":"Intellectual Property","description":"Intellectual property law is crucial to ensuring that you or your organization have exclusive rights to that assets that you’ve created. The BrightTALK intellectual property community has thousands of professionals focused on learning and exchanging information about intellectual property management, intellectual property software and how to protect intellectual property. Join the community for access to free, interactive presentations or attend live webinars to have your questions answered by IP lawyers and industry experts.","alias":"intellectual-property","entryCount":1326,"childCount":0,"enabled":true,"primary":true}]}]},"channelFeed":[{"date":"2024-12-10T14:00:00.000Z","id":628675,"channelId":8395,"thumbnail":{"alt":"Benchmark Litigation Europe Research Webinar","url":"https://cdn.brighttalk.com/ams/california/images/communication/628675/image_1009914.png?width=640\u0026height=360"},"title":"Benchmark Litigation Europe Research Webinar","description":"Introducing Benchmark Litigation Europe's 2025 research webinar on Tuesday 10 December, 2024\n\nWe are thrilled to introduce Benchmark Litigation Europe Rankings and Awards for firms and lawyers, returning in 2025. With just two months to go before the research cycle officially launches, we invite you to register for the upcoming research webinar.\n\nJoin us on 10 December, 2024 at 3pm CET as we shares key dates, new developments, best practices, and more for the research cycle. This webinar is also an opportunity to find out how to amplify your firm's submission and benefit from a live Q\u0026A.\n\nWhat to expect:\n\n- Introduction to the 'three pillars' of the Benchmark Litigation research process\n- Key insights about what our researchers are looking for\n- Updates to jurisdiction coverage, ranking tables and submission formats\n- Tips on how to best complete your submission\n- Q\u0026A\n\nFor more information please contact: researchEU@benchmarklitigation.com.","link":"https://www.brighttalk.com/webcast/8395/628675","status":"upcoming","duration":3600},{"date":"2024-12-04T15:00:00.000Z","id":628979,"channelId":8395,"thumbnail":{"alt":"Freedom-to-operate search tips from IP experts","url":"https://cdn.brighttalk.com/ams/california/images/communication/628979/image_1010107.png?width=640\u0026height=360"},"title":"Freedom-to-operate search tips from IP experts","description":"Join Managing IP and CAS at 3pm GMT (4pm CET) on December 4 to hear scientific intellectual property search experts explain how a tailored freedom-to-operate analysis can help avoid infringement and facilitate the path to market.\n\nExceed client expectations with an expertly curated freedom-to-operate analysis that guides and protects commercialisation. Learn why freedom-to-operate searches in scientific fields such as chemistry and biotechnology present unique challenges that require strategic precision. \n\nJoin scientific intellectual property (IP) search experts Lucy Teixeira Antunes and Christine Hansen, PhD, to avoid infringement and go to market with confidence.\n\nDuring this live webinar, you will learn about:\n• Often overlooked challenges in scientific IP searching;\n• Tips for navigating complex chemical and other scientific searches; and\n• Example solutions to achieve accurate, relevant results.\n\nRegister today and gain practical insights into avoiding the pitfalls of freedom-to-operate patent searches in complex scientific fields.","link":"https://www.brighttalk.com/webcast/8395/628979","status":"upcoming","duration":2700},{"date":"2024-10-08T19:00:00.000Z","id":625339,"channelId":8395,"thumbnail":{"alt":"Benchmark Canada 2025 Research Webinar","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/625339/image_1006557.jpg?width=640\u0026height=360"},"title":"Benchmark Canada 2025 Research Webinar","description":"Join Managing Editor Michael Rafalowich on October 8, 2024 at 3pm ET as he shares key dates, new developments, best practices, and more for this year's research cycle.\n\nThis webinar is also an opportunity to find out how to amplify your firm's submission and benefit from a live Q\u0026A.\n\nWhat to expect:\n\n- Introduction to the 'three pillars' of the Benchmark Litigation research process\n- Key insights about what our researchers are looking for\n- Updates to jurisdiction coverage, ranking tables and submission formats\n- The details you can and should you include in your submission\n- Tips on making the submission process efficient\n- Q\u0026A.","link":"https://www.brighttalk.com/webcast/8395/625339","status":"recorded","duration":4968},{"date":"2024-09-19T07:00:00.000Z","id":622768,"channelId":8395,"thumbnail":{"alt":"IP STARS rankings and Managing IP Awards 2025","url":"https://cdn.brighttalk.com/ams/california/images/communication/622768/image_997190.png?width=640\u0026height=360"},"title":"IP STARS rankings and Managing IP Awards 2025","description":"This Q\u0026A webinar has been set up to accommodate people, especially in the Asia-Pacific region, who were unable to join or participate in our global webinar on 17 September. \n\nRegister for this webinar to ask questions about the research for the 2025 edition of IP STARS rankings and the Managing IP Awards programme. Registrants unable to join the live webinar will get an email notification about the recording.\n\nPlease make sure you listen to our global webinar before joining this webinar. You can send your questions in advance to research@managingip.com.\n\nRead about the research on ipstars.com or www.ipstars.com/NewsAndAnalysis/The-research-for-the-IP-STARS-rankings-and-Managing-IP-Awards/Index/4176","link":"https://www.brighttalk.com/webcast/8395/622768","status":"recorded","duration":5057},{"date":"2024-09-17T13:00:00.000Z","id":621446,"channelId":8395,"thumbnail":{"alt":"IP STARS rankings and Managing IP Awards 2025","url":"https://cdn.brighttalk.com/ams/california/images/communication/621446/image_997191.png?width=640\u0026height=360"},"title":"IP STARS rankings and Managing IP Awards 2025","description":"Register for this webinar to learn about the research for the 2025 edition of IP STARS rankings and the Managing IP Awards programme. Registrants unable to join the live webinar will get an email notification about the recording.\n\nAgenda\n1. Learn about our research for the rankings and awards\n2. An overview of the 2025 forms and how to use the submission portal\n3. Best practice tips and key research dates\n4. Q \u0026 A (you can send your questions in advance to research@managingip.com)\n\nPlease also read about the research on ipstars.com or www.ipstars.com/NewsAndAnalysis/The-research-for-the-IP-STARS-rankings-and-Managing-IP-Awards/Index/4176 and listen to our 2024 webinar at https://www.ipstars.com/NewsAndAnalysis/2024-research-webinar-recording-now-available/Index/9306","link":"https://www.brighttalk.com/webcast/8395/621446","status":"recorded","duration":5389},{"date":"2024-09-13T07:00:00.000Z","id":623130,"channelId":8395,"thumbnail":{"alt":"Benchmark Litigation 中国 2025-调研研讨会","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/623130/image_1001774.jpg?width=640\u0026height=360"},"title":"Benchmark Litigation 中国 2025-调研研讨会","description":"2025年调研概览调研指南和时间线如何完成材料申报问答环节","link":"https://www.brighttalk.com/webcast/8395/623130","status":"recorded","duration":2781},{"date":"2024-09-12T07:00:00.000Z","id":623128,"channelId":8395,"thumbnail":{"alt":"Benchmark Litigation Asia-Pacific Research 2025","url":"https://cdn.brighttalk.com/ams/california/images/communication/623128/image_1000829.png?width=640\u0026height=360"},"title":"Benchmark Litigation Asia-Pacific Research 2025","description":"We will go through the research methodology, walk you through the submission process, and provide some tips to complete submissions efficiently. There will be a live Q\u0026A portion at the end of the presentation.","link":"https://www.brighttalk.com/webcast/8395/623128","status":"recorded","duration":3580},{"date":"2024-09-02T13:50:00.000Z","id":624303,"channelId":8395,"thumbnail":{"alt":"Testing recorded content","url":""},"title":"Testing recorded content","description":"tesgfveag","link":"https://www.brighttalk.com/webcast/8395/624303","status":"recorded","duration":48},{"date":"2024-06-27T16:00:00.000Z","id":617154,"channelId":8395,"thumbnail":{"alt":"Real-world wins from brands using online brand protection","url":"https://cdn.brighttalk.com/ams/california/images/communication/617154/image_994174.png?width=640\u0026height=360"},"title":"Real-world wins from brands using online brand protection","description":"As new marketplaces continue to emerge and an increasing number of third-party sellers flood the market with counterfeit goods, the issue of protecting your brand has become more challenging and critical than ever before. Companies often proactively register their intellectual property as a defensive measure, but effective enforcement in the global market demands more than just legal protection.\n\nThis webinar will delve into practical use cases presented by industry experts, highlighting specific challenges encountered by real-life brands and the strategies they employed to combat the ‘whack-a-mole’ effect.\n\nThe following will be covered by Daniel Shapiro and Jana Miles Paskova, respectively Red Points’ senior vice president of brand relationships and strategic partnerships, and senior enterprise customer success manager:\n• Case studies from well-known brands dealing with large issues concerning counterfeiting and impersonation;\n• Learning how companies navigate the complexities of protecting their intellectual property in a global marketplace;\n• Discovering how AI is revolutionising brand protection, boosting online enforcement and offline litigation, and making strategies more effective and expansive; and\n• How to develop practical strategies and innovative approaches that you can apply to safeguard your brand.\n\nDo not miss out on this opportunity to transform your brand protection efforts into a robust and proactive strategy.","link":"https://www.brighttalk.com/webcast/8395/617154","status":"recorded","duration":3550},{"date":"2024-03-14T07:00:00.000Z","id":607960,"channelId":8395,"thumbnail":{"alt":"asialaw research 2024 | research webinar","url":"https://cdn.brighttalk.com/ams/california/images/communication/607960/image_967208.png?width=640\u0026height=360"},"title":"asialaw research 2024 | research webinar","description":"In this webinar, we will provide more information on the annual research process, including how to prepare submissions and the timescale of the research.\n\nThis is a unique opportunity to get guidance on legal directory submissions and ask questions. The webinar is recorded and will be available thereafter if you are unable to participate live. Simply register to receive notification of the recording.\n\nThings to expect include:\n• Introduction to asialaw research 2024\n• Step-by-step guide to the submission process\n• Timeline of the research\n• asialaw Awards 2024\n• Q\u0026A","link":"https://www.brighttalk.com/webcast/8395/607960","status":"recorded","duration":1739},{"date":"2024-02-06T19:00:00.000Z","id":599574,"channelId":8395,"thumbnail":{"alt":"Benchmark Litigation USA 2025 Research Webinar","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/599574/image_965306.jpg?width=640\u0026height=360"},"title":"Benchmark Litigation USA 2025 Research Webinar","description":"Benchmark Litigation USA, as well as Benchmark Labor \u0026 Employment, will share key research guidelines, timelines and helpful information for the upcoming research cycle. A Q\u0026A session will follow the presentation.","link":"https://www.brighttalk.com/webcast/8395/599574","status":"recorded","duration":5719},{"date":"2024-02-01T07:00:00.000Z","id":605267,"channelId":8395,"thumbnail":{"alt":"IFLR1000中国2024调研研讨会|立即注册","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/605267/image_964449.jpg?width=640\u0026height=360"},"title":"IFLR1000中国2024调研研讨会|立即注册","description":"立即注册我们线上调研研讨会，您将了解如何最大限度地利用调研表格所需的一切信息。如果您无法参加直播，您可以观看录制视频，但您必须完成注册以获得录屏。\n\n我们的中国调研员沙淼将于2024年2月1日北京时间下午三点，与大家分享如何才能提交一份出色的调研表格，以及如何在 2024 年的排名中取得成功。\n\n如果您想让贵所在 2024 年跻身表现最佳的律师事务所行列，那就一定不能错过这次机会！\n\n您可以期待什么:\n\n• IFLR1000 中国调研流程介绍\n• 调研人员在调研表格中寻求哪些信息？\n• 您应在调研表格中包含的具体信息\n• 什么成就了一份优秀的调研表格？\n• 线上答疑","link":"https://www.brighttalk.com/webcast/8395/605267","status":"recorded","duration":1761},{"date":"2024-01-18T14:00:00.000Z","id":603857,"channelId":8395,"thumbnail":{"alt":"IFLR1000 Research Submission Live Q\u0026A","url":"https://cdn.brighttalk.com/ams/california/images/communication/603857/image_959432.png?width=640\u0026height=360"},"title":"IFLR1000 Research Submission Live Q\u0026A","description":"Don't miss our live Q\u0026A session with our Global Editor, Danielle Ngwana-Joseph on the 18th of January at 2pm GMT. \n\nDuring this session, you'll have the chance to get your top questions about the 2024 submission process answered. \n\n\nLearn how to maximise your submission and improve your chances of having your firm and lawyers recognised among the top performing law firms in 2024.","link":"https://www.brighttalk.com/webcast/8395/603857","status":"recorded","duration":4739},{"date":"2023-12-12T16:26:00.000Z","id":603291,"channelId":8395,"thumbnail":{"alt":"IFLR1000 2024 Research Webinar (On-Demand)","url":"https://cdn.brighttalk.com/ams/california/images/communication/603291/image_958707.png?width=640\u0026height=360"},"title":"IFLR1000 2024 Research Webinar (On-Demand)","description":"IFLR1000 Global Editor, Danielle Ngwana-Joseph tells you everything you need to know to maximise your company and practitioner rankings for the IFLR1000 global rankings, exposing your work to its global audience of financial and corporate professionals at the world's largest corporations across all sectors. \n\nWhat to expect: \n\n- Introduction to the IFLR1000 research process\n\n- What information our researchers look for in a submission\n\n- Details you should include in your submission\n\n- What makes a great submission","link":"https://www.brighttalk.com/webcast/8395/603291","status":"recorded","duration":1166},{"date":"2023-10-18T19:00:00.000Z","id":595567,"channelId":8395,"thumbnail":{"alt":"Benchmark Canada 2024 Research Webinar","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/595567/image_949267.jpg?width=640\u0026height=360"},"title":"Benchmark Canada 2024 Research Webinar","description":"Editor Michael Rafalowich key research guidelines, timelines and helpful information for the upcoming 2024 research cycle for Benchmark Litigation Canada.","link":"https://www.brighttalk.com/webcast/8395/595567","status":"recorded","duration":5106},{"date":"2023-09-14T14:00:00.000Z","id":591016,"channelId":8395,"thumbnail":{"alt":"IP STARS rankings and Managing IP Awards 2024","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/591016/image_942481.jpg?width=640\u0026height=360"},"title":"IP STARS rankings and Managing IP Awards 2024","description":"Register for this webinar to learn about the research for the 2024 edition of IP STARS rankings and the Managing IP Awards programme. Registrants unable to join the live webinar will get an email notification about the recording.\n\nAgenda\n1. Learn about our research for the rankings and awards\n2. An overview of the 2024 forms and how to use the submission portal\n3. Best practice tips and key research dates\n4. Q \u0026 A\n\nRead about the research on ipstars.com or www.ipstars.com/NewsAndAnalysis/The-research-for-the-IP-STARS-rankings-and-Managing-IP-Awards/Index/4176","link":"https://www.brighttalk.com/webcast/8395/591016","status":"recorded","duration":5378},{"date":"2023-09-14T07:00:00.000Z","id":592025,"channelId":8395,"thumbnail":{"alt":"Benchmark Litigation 中国 2024-调研研讨会","url":"https://cdn.brighttalk.com/ams/ireland/images/communication/592025/image_942364.jpg?width=640\u0026height=360"},"title":"Benchmark Litigation 中国 2024-调研研讨会","description":"2024年调研概览调研指南和时间线如何完成材料申报问答环节","link":"https://www.brighttalk.com/webcast/8395/592025","status":"recorded","duration":3589}],"envVariables":{"hostUrl":"https://www.brighttalk.com","gtmId":"GTM-WL9H26","envValue":"prod","cloudinaryEnv":"brighttalkprod","staticAssetCdnUrl":"https://assets.brighttalk.com","nextPublicSentryDSN":"https://85b928fa6c7a4e9985f029323783cd54@o311348.ingest.sentry.io/5438623"}},"__N_SSP":true},"page":"/[channelId]/[webcastId]","query":{"bt_tok":"{{Recipient.ID}}","utm_source":"LegalBenchmarkingGroup","utm_medium":"brighttalk","utm_campaign":"618737","channelId":"8395","webcastId":"618737"},"buildId":"1079","assetPrefix":"/webcast","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[12910,75479,93394],"gssp":true,"appGip":true,"scriptLoader":[]}</script><script> window.dataLayer = window.dataLayer || []; dataLayer.push({ 'brighttalk-page-name': 'webcast', 'brighttalk-portal-is-logged-in': false });</script><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WL9H26');</script><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WL9H26" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></body></html>